Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML)

HFL Mark, RA Sokolic, Y Mark - Experimental and molecular pathology, 2006 - Elsevier
Chronic myeloid leukemia (CML) is the prototype cytogenetic malignancy. Even before the
development of basic G-banding techniques, CML was found to be associated with a …

Chronic myelogenous leukemia, version 1.2015

S O'Brien, JP Radich, CN Abboud, M Akhtari… - Journal of the National …, 2014 - jnccn.org
Chronic myelogenous leukemia (CML) is usually diagnosed in the chronic phase. Untreated
chronic phase CML will eventually progress to advanced phase (accelerated or blast phase) …

Chronic myelogenous leukemia

S O'Brien, CN Abboud, M Akhtari, J Altman… - Journal of the National …, 2012 - jnccn.org
Chronic Myelogenous Leukemia in: Journal of the National Comprehensive Cancer Network
Volume 10 Issue 1 (2012) Jump to Content User Account Sign In to save searches and organize …

[PDF][PDF] Inhibidores de cinasas de tirosina (ICT): la nueva revolución en el tratamiento de la leucemia mieloide crónica (LMC)

S Avilés-Vázquez, A Chávez-González… - Gaceta médica de …, 2013 - researchgate.net
La LMC es una neoplasia mieloproliferativa clonal, asociada a la translocación recíproca t
(9, 22)(q34: q11), conocida como cromosoma Filadelfia (Ph). De esta translocación se …

[HTML][HTML] Role and mechanism of decitabine combined with tyrosine kinase inhibitors in advanced chronic myeloid leukemia cells

LC Jiang, JM Luo - Oncology Letters, 2017 - spandidos-publications.com
Patients with advanced chronic myeloid leukemia (CML) have a poor prognosis, with the
use of tyrosine kinase inhibitors (TKIs) to treat CML demonstrating poor results. The results …

[HTML][HTML] Avaliação laboratorial da doença residual mínima na leucemia mielóide crônica por Real-Time PCR

AC Grando, SC Wagner - Jornal Brasileiro de Patologia e Medicina …, 2008 - SciELO Brasil
A leucemia mielóide crônica (LMC) representa 15% das leucemias e apresenta três fases:
crônica, acelerada e crise blástica. A partir da análise citogenética, pode ser identificado o …

Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)

S Avilés-Vázquez, A Chávez-González… - Gaceta medica de …, 2013 - medigraphic.com
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasia associated with
the t (9, 22)(q34: q11) reciprocal translocation, also known as Philadelphia chromosome …

Evaluación de la atención farmacéutica y del envío domiciliario de medicación a pacientes con leucemia mieloide crónica: proyecto TICAFAN

B San José Ruiz, G Lemus, G Ros Bernaola… - Revista de la …, 2020 - SciELO Espana
Resumen SAN JOSE RUIZ, B et al. Evaluation of pharmaceutical care and home delivery of
medication to patients with chronic myeloid leukemia-TICAFAN Project. Rev. OFIL· ILAPHAR …

[PDF][PDF] Baseline Tryptase Levels Correlate with Baseline Basophil Levels in Chronic Myeloid Leukemia-Chronic Phase

A Mathew, M Naithani, S Saha, R Chetia… - Journal of Advances in …, 2020 - researchgate.net
Aims: To study whether there is any correlation between baseline blood basophil count and
serum tryptase levels in newly diagnosed chronic phase chronic myeloid leukemia (CML …

[HTML][HTML] Niveles de anticuerpos naturales antibanda 3 y de hemoglobina en enfermos con leucemia mieloide crónica

R Villaescusa Blanco, AA Arce Hernández… - Revista Cubana de …, 2016 - scielo.sld.cu
Introducción: La leucemia mieloide crónica (LMC) se caracteriza por una producción
excesiva de células mieloides y sus progenitores; además se observan trastornos …